Diploma PLC (LON:DPLM - Get Free Report) insider David S. Lowden bought 750 shares of the business's stock in a transaction on Friday, March 21st. The shares were acquired at an average price of GBX 3,928 ($50.76) per share, with a total value of £29,460 ($38,066.93).
Diploma Stock Performance
LON DPLM opened at GBX 3,982 ($51.45) on Tuesday. The business's 50-day moving average price is GBX 4,388.20 and its 200 day moving average price is GBX 4,381.82. The company has a current ratio of 2.17, a quick ratio of 0.80 and a debt-to-equity ratio of 62.17. Diploma PLC has a twelve month low of GBX 3,372 ($43.57) and a twelve month high of GBX 4,808 ($62.13). The company has a market capitalization of £5.31 billion, a PE ratio of 45.77, a price-to-earnings-growth ratio of 2.82 and a beta of 0.75.
Diploma Increases Dividend
The business also recently disclosed a dividend, which was paid on Friday, January 31st. Stockholders of record on Thursday, January 16th were issued a dividend of GBX 42 ($0.54) per share. This is a positive change from Diploma's previous dividend of $17.30. This represents a dividend yield of 0.93%. The ex-dividend date of this dividend was Thursday, January 16th. Diploma's dividend payout ratio is presently 65.52%.
Wall Street Analysts Forecast Growth
Separately, JPMorgan Chase & Co. lifted their price objective on Diploma from GBX 4,370 ($56.47) to GBX 4,420 ($57.11) and gave the stock a "neutral" rating in a research report on Tuesday, January 14th. Two research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat, Diploma currently has a consensus rating of "Moderate Buy" and an average target price of GBX 4,567.50 ($59.02).
Check Out Our Latest Analysis on Diploma
About Diploma
(
Get Free Report)
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to contact@insidertrades.com.
